We also showed that BRG1 is essential for maintaining the stem cell-like identity of GBM cancer stem cells (GSCs) [11], and BRG1 knockdown in GSCs and in GBM cell lines increases chemosensitivity to the standard-of-care DNA alkylating agent TMZ [11,12]. Here, SMARCA4 is linked to glioblastoma.